Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Caoimh Russell"'
Publikováno v:
International journal of geriatric psychiatry. 37(8)
Aducanumab is a monoclonal antibody which has recently been licenced for use by the food and drug administration for treatment of patients with mild cognitive impairment due to Alzheimer's disease (AD) or mild AD dementia. Appropriate use criteria (A